Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Artigo | IMSEAR | ID: sea-211415

RESUMO

Breast carcinoma is one of the most common and dreaded diseases of women, and in Nepal, it is second most common cancer. The situation is more alarming in the rural areas where the majority of women are illiterate and ignorant about the hazards of breast cancer. Different screening strategies such as rural cancer registries and camp approach for cancer detection have been found useful in minimizing the problem of breast cancer in the villages. Advanced presentation of breast cancer and the problem of late diagnosis is well documented in Nepal. Moreover, diagnostic workup, treatment and palliative services are inadequate in most parts of Nepal. A better understanding current situation of breast cancer can help government to formulate breast cancer prevention strategy in Nepal. In this review, authors present an overview of the burden of breast cancer, risk factors, screening, and cancer care among Nepalese women.

2.
Artigo em Inglês | IMSEAR | ID: sea-173692

RESUMO

At the current rate of decline in infant mortality, India is unlikely to achieve the Millennium Development Goal on child survival. Integrated Management of Neonatal and Childhood Illness (IMNCI), adapted from the global Integrated Management of Childhood Illness to enhance the focus on newborns and on community health workers, is the central strategy within the National Reproductive and Child Health Programme to address high infant mortality. This paper assessed the progress of IMNCI in India, identified the programme bottlenecks, and also assessed the effect on coverage of key newborn and childcare practices. Programme data were analyzed to ascertain the implementation status; rapid programme assessment was conducted for identifying the programme bottlenecks; and results of analysis of two rounds of district-level household surveys were used for comparing the change in the coverage of child-health interventions in IMNCI and control districts. More than 200,000 community health workers and first-level healthcare providers were trained during 2005-2009 at a variable pace across 223 districts. Of the reported births (n=1,102,573), 65.5% were visited by a trained worker within 24 hours, and 63.1% were visited three times within 10 days. Poor supervision and inadequate essential supplies affected the performance of trained workers. During 2004-2008, 12 early-implementing districts had covered most key newborn and child practice indicators compared to the control districts; however, the difference was significant only for care-seeking for acute respiratory infection (net difference: 17.8%; 95% confidence interval 2.3-33.2, p<0.026). Based on the early experience of IMNCI implementation in different states of India, measures need to be taken to improve supportive supervision, availability of essential supplies, and monitoring of the programme if the strategy has to translate into improved child survival in India.

3.
Indian J Exp Biol ; 2003 Dec; 41(12): 1456-9
Artigo em Inglês | IMSEAR | ID: sea-60317

RESUMO

Due to similarities in lipid metabolism to those in humans, hamster is considered as a good model for the study of regulatory mechanisms of plasma lipoproteins in response to cholesterol or fatty acid-enriched diet. This model of hyperlipidemia has been modified to produce dyslipidedmia with diabetes complexities by feeding with high fat diet added with 9% (w/w) fructose. Feeding this diet to hamster for 10 days markedly increases plasma levels of triglyceride, cholesterol, fatty acids followed by a significant increase in glycerol, beta lipoproteins, high density lipoprotein, glucose and glycosylated proteins. This model is being used for research and development of lipid lowering drugs with hypoglycemic activity in collaboration with Novo Nordisk, Denmark. The modified high fat diet formulation has now been prepared (Research diet D.99122211) and supplied by Research Diets Inc, Burnswick USA.


Assuntos
Animais , Hipolipemiantes/uso terapêutico , Cricetinae , Diabetes Mellitus Experimental/complicações , Gorduras na Dieta/administração & dosagem , Modelos Animais de Doenças , Hiperlipidemias/complicações , Fenofibrato/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA